MedTrace Logo

Zinc as Adjunct to Treatment of Pneumonia

NCT00513929 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 450

Last updated 2009-01-29

No results posted yet for this study

Summary

The propose of this study is to evaluate if zinc given as an adjunct to standard treatment of severe pneumonia in young children shortens the duration and reduces treatment failure, and if these effects are pathogen-dependant.

Conditions

Interventions

DIETARY_SUPPLEMENT

Zinc sulphate

Arm X : Zinc sulphate 10 mg will be given orally twice a day since admission to resolution of pneumonia episode in addition to standard antibiotic treatment.

Sponsors & Collaborators

  • Boston University

    collaborator OTHER

  • Corporacion Ecuatoriana de Biotecnologia

    lead OTHER

Principal Investigators

  • Fernando E Sempertegui, MD · Corporacion Ecuatoriana de Biotecnologia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
2 Months
Max Age
59 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2010-05-31
Completion
2010-05-31

Countries

  • Ecuador

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00513929 on ClinicalTrials.gov